COMPOSITION
Quixin™ : Each tablet contains Lavofloxacin Hemihydrate INN equivalent to Lavofloxacin 500 mg.
PHARMACOLOGICAL INFORMATION
Pharmacological Action
Quixin (Lavofloxacin) is a broad-spectrum fluoroquinolone antibiotic with proven activity against bacteria. It acts by inhibiting bacterial DNA gyrase.
Mechanism of Action
Quixin (Levofloxacin) b locks bacterial DNA synthesis by inhibiting bacterial topoisomerase II (DNA gyrase) and topoisomerase IV. Inhibition of DNA gyrase prevents the relaxation of positively supercoiled DNA that is required for normal transcription and replication. Inhibition of topoisomerase IV interferes with the separation of replicated chromosomal DNA into respective daughter cells during cell division.
Pharmacokinetic properties
Levofloxacin is rapidly and completely absorbed after oral administration. Peak plasma concentration is usually attained one to two hours after oral administration. The absolute bioavailability of a 500mg Levofloxacin tablet is approximately 99%, demonstrating complete oral absorption of Levofloxacin. Levofloxacin reaches its peak levels in skin tissues of healthy subjects at approximately 3 hours after dosing. After oral administration, approximately 87% of an administrated dose as recovered as unchanged drug in urine within 48 hours. No Levofloxacin crystals were found in any of the urine samples freshly collected from subjects receiving Levofloxacin.
CLINICAL INFORMATION
Therapeutic Indications
Quixin (Lavofloxacin) is used for the treatment of single or mixed infections caused by two or more susceptible organisms.It is recommended for the following indications
- Acute maxillary sinusitis
- Acute bacterial exacerbation of chronic bronchitis
- Community-acquired pneumonia
- Acute Pyelonephritis
- Uncomplicated & complicated skin and soft tissue infections
- Uncomplicated & complicated urinary tract infections
Dosage And Administration
Indications |
Daily Dose |
Duration |
Acute sinusitis |
500 mg |
10-14 days |
Exacerbation of chronic bronchitis |
250-500mg |
7 days |
Community-acquired pneumonia, |
500 mg |
7-14 days |
Complicated urinary-tract infections and acute Pyelonephritis |
250 mg |
7-10 days |
Uncomplicated skin and soft-tissue infections |
500 mg |
7-10 days |
Complicated skin and soft-tissue infections |
750 mg |
7-10 days |
Use in Pregnancy & Lactation
Pregnant women : In animal studies Levofloxacin does not appear to be teratogenic but it may damage developing cartilage. There are insufficient data to recommend the use of Lavofloxacin on pregnancy.
Lactating Mother : Levofloxacin does cross into the breast milk and its use during lactation is not advised.
Use in Children
If possible quinolone antibiotics should be avoided in childhood because of the effects on cartilage.
Use in Elderly
Although higher Levofloxacin serum levels is found in elderly, no dosage adjustment is necessary .
Use in patient with impaired liver function
In studies in patients with stable chronic cirrhosis, no significant changes in Levofloxacin pharmacokinetics have been observed. The kinetics of Levofloxacin in patients with acute hepatic insufficiency, however, has not been fully evaluated.
Use in patient with impaired renal function
Dosage adjustments are usually not required, except in patients with severe renal impairment (creatinine clecrance <20 ml/minute).If adjustment is necessary; this may be achieved by reducing the total daily dose by half .
Side Effects
Levofloxacin is generally well tolerated. However, a few side effects can usually be seen. Side effects include: nausea, vomiting, diarrhea, abdominal pain, flatulence and rare occurrence of photo-toxicity (0.1%). Side effects that may be seen very rarely include tremors, depression, anxiety, confusion etc .
Contraindications
Levofloxacin is contraindicated in patients with a history of hypersensitivity to Levofloxacin, quinolones antimicrobial agent, or any other components of this product.
Drug Interaction
Antacids, Iron and Adsorbents-reduce absorption of Levofloxacin. NSAIDs may increase the risk of CNS stimulation. Warfarin may increase the risk of bleeding.
Over Dosage & Treatment
In the event of acute, excessive oral overdosage, reversible renal toxicity has been reported in some cases. Therefore, apart from routine emergency measures, it is recommended to monitor renal function and to administer Mg or Ca-containing antacids which reduce the absorption of Levofloxacin.
PHARMACEUTICAL INFORMATION
Storage Conditions
Store in a cool and dry place, away from light. Keep out of reach of children.
Presentation & packaging
Quixin™: Each commercial box contains 30 tablets in Alu-PVDC blister pack |